Related Experiment Video
Updated: Oct 4, 2025

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
Well-differentiated liver cancers reveal the potential link between ACE2 dysfunction and metabolic breakdown
Lise Desquilles1, Luis Cano1, Gevorg Ghukasyan2
1INSERM, INRAE, University of Rennes, Nutrition Metabolisms and Cancer, Rennes, France.
Abstract:
Angiotensin-converting enzyme 2 (ACE2) is the receptor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing Coronavirus disease 2019 (COVID-19). Transmembrane serine protease 2 (TMPRSS2) is a coreceptor. Abnormal hepatic function in COVID-19 suggests specific or bystander liver disease. Because liver cancer cells express the ACE2 viral receptor, they are widely used as models of SARS-CoV-2 infection in vitro. Therefore, the purpose of this study was to analyze ACE2 and TMPRSS2 expression and localization in human liver cancers and in non-tumor livers. We studied ACE2 and TMPRSS2 in transcriptomic datasets totaling 1503 liver cancers, followed by high-resolution confocal multiplex immunohistochemistry and quantitative image analysis of a 41-HCC tissue microarray. In cancers, we detected ACE2 and TMPRSS2 at the biliary pole of tumor hepatocytes. In whole mount sections of five normal liver samples, we identified ACE2 in hepatocyte's bile canaliculi, biliary epithelium, sinusoidal and capillary endothelial cells. Tumors carrying mutated β-catenin showed ACE2 DNA hypomethylation and higher mRNA and protein expression, consistently with predicted β-catenin response sites in the ACE2 promoter. Finally, ACE2 and TMPRSS2 co-expression networks highlighted hepatocyte-specific functions, oxidative stress and inflammation, suggesting a link between inflammation, ACE2 dysfunction and metabolic breakdown.
Insights
This study investigated Angiotensin-converting enzyme 2 (ACE2) and Transmembrane serine protease 2 (TMPRSS2) in liver cancer. Findings reveal their expression in tumor hepatocytes, linking inflammation and metabolic dysfunction in liver disease.
Area of Science:
- Hepatology
- Virology
- Oncology
Background:
- Angiotensin-converting enzyme 2 (ACE2) is the SARS-CoV-2 receptor, and TMPRSS2 is a coreceptor.
- COVID-19 can cause abnormal liver function, indicating potential liver disease.
- Liver cancer cells express ACE2, making them useful models for SARS-CoV-2 infection studies.
Purpose of the Study:
- To analyze the expression and localization of ACE2 and TMPRSS2 in human liver cancers and non-tumor liver tissues.
- To investigate the relationship between ACE2 expression and tumor characteristics, including beta-catenin mutations.
- To explore the functional implications of ACE2 and TMPRSS2 co-expression in the liver.
Main Methods:
- Analysis of transcriptomic datasets from 1503 liver cancers.
- High-resolution confocal multiplex immunohistochemistry on a 41-HCC tissue microarray.
- Quantitative image analysis of protein expression and localization.
Main Results:
- ACE2 and TMPRSS2 were detected at the biliary pole of tumor hepatocytes.
- ACE2 was identified in normal liver cells, including hepatocytes, biliary epithelium, and endothelial cells.
- Mutated beta-catenin in tumors correlated with ACE2 DNA hypomethylation and increased ACE2 expression.
- Co-expression networks indicated roles in hepatocyte-specific functions, oxidative stress, and inflammation.
Conclusions:
- ACE2 and TMPRSS2 are expressed in human liver cancer and normal liver tissues.
- Beta-catenin mutations influence ACE2 expression in liver cancer.
- ACE2 and TMPRSS2 co-expression suggests a link between inflammation, ACE2 dysfunction, and metabolic breakdown in the liver.
More Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Cell Specific Gene Expression
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...